EUVIMEDEUVIMED entdecken
Open Access

Elevated autoantibodies against dipeptidyl peptidase-4 are associated with poor prognosis in patients with type 2 diabetes

Takeshi Yagihashi, Takahide Hashimoto, Naoki Ohtake, Tokiko Okamoto, Bo-Shi Zhang, Yoichi Yoshida, Masaya Yamaga, Tomohiko Yoshida, Amika Kajiyama, Rikako Furukawa, Takaki Hiwasa, Minoru Takemoto

Endocrine Journal · 2026 · 73 (11) · 1185-1191

DOI: 10.1507/endocrj.ej26-0170 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrine Journal, 2026. Verfasst von Takeshi Yagihashi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diabetes, Metabolism and Endocrinology, International University of Health and Welfare, Narita Hospital, Chiba 286-8520, Japan. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Autoantibodies, Dipeptidyl Peptidase 4. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2AutoantibodiesDipeptidyl Peptidase 4HumansFemalePrognosisMaleMiddle AgedAgedBiomarkersProportional Hazards Models

Stichwörter der Autor:innen

BiomarkersDPP4 antibodiesDipeptidyl peptidase-4MortalityType 2 diabetes

Substanzen

AutoantibodiesDipeptidyl Peptidase 4DPP4 protein, humanBiomarkers

Autor:innen und Institutionen

  • Department of Diabetes, Metabolism and Endocrinology, International University of Health and Welfare, Narita Hospital, Chiba 286-8520, Japan.
  • Department of Diabetes, Metabolism and Endocrinology, International University of Health and Welfare, Atami Hospital, Shizuoka 413-0012, Japan.
  • Department of Neurological Surgery, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
  • Department of Diabetes, Metabolism and Endocrinology, School of Medicine, International University of Health and Welfare, Chiba 286-8686, Japan.

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Yagihashi, T., Hashimoto, T., Ohtake, N., Okamoto, T., Zhang, B. S., Yoshida, Y., Yamaga, M., Yoshida, T., Kajiyama, A., Furukawa, R., Hiwasa, T., & Takemoto, M. (2026). Elevated autoantibodies against dipeptidyl peptidase-4 are associated with poor prognosis in patients with type 2 diabetes. Endocrine Journal, 73(11), 1185-1191. https://doi.org/10.1507/endocrj.ej26-0170

Vancouver

Yagihashi T, Hashimoto T, Ohtake N, Okamoto T, Zhang BS, Yoshida Y, et al. Elevated autoantibodies against dipeptidyl peptidase-4 are associated with poor prognosis in patients with type 2 diabetes. Endocrine Journal. 2026;73(11):1185-1191. doi:10.1507/endocrj.ej26-0170

BibTeX
@article{Yagihashi2026,
  author = {Yagihashi, Takeshi and Hashimoto, Takahide and Ohtake, Naoki and Okamoto, Tokiko and Zhang, Bo-Shi and Yoshida, Yoichi and Yamaga, Masaya and Yoshida, Tomohiko and Kajiyama, Amika and Furukawa, Rikako and Hiwasa, Takaki and Takemoto, Minoru},
  title = {Elevated autoantibodies against dipeptidyl peptidase-4 are associated with poor prognosis in patients with type 2 diabetes},
  journal = {Endocrine Journal},
  year = {2026},
  volume = {73},
  number = {11},
  pages = {1185--1191},
  doi = {10.1507/endocrj.ej26-0170}
}
Kostenlos starten →